Turnpike
Payments companies reported to CMS as associated with Turnpike. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Turnpike, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Turnpike
These are the largest totals companies reported as associated with Turnpike. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rhian Davies | York, PA | Cardiovascular Disease | $37,796.43 |
| Kevin Croce | Chestnut Hill, MA | Cardiovascular Disease | $36,157.82 |
| Lorenzo Azzalini | Seattle, WA | Interventional Cardiology | $20,373.05 |
| William Nicholson | Atlanta, GA | Interventional Cardiology | $18,617.86 |
| Kathleen Kearney | Seattle, WA | Interventional Cardiology | $16,285.21 |
| Brian Bergmark | Boston, MA | Cardiovascular Disease | $9,725.04 |
| Margaret Mcentegart | New York, NY | Interventional Cardiology | $8,100.00 |
| James Grantham | Kansas City, MO | Interventional Cardiology | $7,562.73 |
| Craig Thompson | Hartford, CT | Interventional Cardiology | $6,900.83 |
| Dimitrios Karmpaliotis | Morristown, NJ | Interventional Cardiology | $6,887.50 |
Prescribed Turnpike?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.